Page 26 - Read Online

Page 22 of 23 Skoreński et al. Rare Dis Orphan Drugs J 2023;2:6 https://dx.doi.org/10.20517/rdodj.2022.21

64. DOI PubMed
33. Wysocka M, Lesner A, Gruba N, et al. Three wavelength substrate system of neutrophil serine proteinases. Anal Chem 2012;84:7241-
8. DOI PubMed
34. Sun Q, Li J, Liu WN, Dong QJ, Yang WC, Yang GF. Non-peptide-based fluorogenic small-molecule probe for elastase. Anal Chem
2013;85:11304-11. DOI PubMed
35. Aikawa N, Kawasaki Y. Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress
syndrome. Ther Clin Risk Manag 2014;10:621-9. DOI PubMed PMC
36. Powers JC, Gupton BF, Harley AD, Nishino N, Whitley RJ. Specificity of porcine pancreatic elastase, human leukocyte elastase and
cathepsin G. Inhibition with peptide chloromethyl ketones. Biochim Biophys Acta 1977;485:156-66. DOI PubMed
37. Jugniot N, Voisin P, Bentaher A, Mellet P. Neutrophil elastase activity imaging: recent approaches in the design and applications of
activity-based probes and substrate-based probes. Contrast Media Mol Imaging 2019;2019:7417192. DOI PubMed PMC
38. Winiarski Ł, Oleksyszyn J, Sieńczyk M. Human neutrophil elastase phosphonic inhibitors with improved potency of action. J Med
Chem 2012;55:6541-53. DOI PubMed
39. António JPM, Gonçalves LM, Guedes RC, Moreira R, Gois PMP. Diazaborines as new inhibitors of human neutrophil elastase. ACS
Omega 2018;3:7418-23. DOI PubMed PMC
40. Zheng Q, Woehl JL, Kitamura S, et al. SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase. Proc
Natl Acad Sci USA 2019;116:18808-14. DOI PubMed PMC
41. Xu Y, Qi N, Wen H, Zhang G, Wang Y, Cui H. Synthesis and evaluation of benzenesulfonic acid derivatives as human neutrophil
elastase (hNE) inhibitors. Med Chem Res 2021;30:387-98. DOI PubMed PMC
42. Al-Horani RA, Aliter KF, Kar S, Mottamal M. Sulfonated nonsaccharide heparin mimetics are potent and noncompetitive inhibitors of
human neutrophil elastase. ACS Omega 2021;6:12699-710. DOI PubMed PMC
43. Ruivo EF, Gonçalves LM, Carvalho LA, et al. Clickable 4-Oxo-β-lactam-based selective probing for human neutrophil elastase related
proteomes. ChemMedChem 2016;11:2037-42. DOI PubMed
44. Schulz-Fincke AC, Tikhomirov AS, Braune A, et al. Design of an activity-based probe for human neutrophil elastase: implementation
of the lossen rearrangement to induce förster resonance energy transfers. Biochemistry 2018;57:742-52. DOI PubMed
45. Anderson BM, Poole DP, Aurelio L, et al. Application of a chemical probe to detect neutrophil elastase activation during inflammatory
bowel disease. Sci Rep 2019;9:13295. DOI PubMed PMC
46. Liu SY, Xiong H, Li RR, Yang WC, Yang GF. Activity-based near-infrared fluorogenic probe for enabling in vitro and in vivo
profiling of neutrophil elastase. Anal Chem 2019;91:3877-84. DOI PubMed
47. Ahmad S, Saleem M, Riaz N, et al. The natural polypeptides as significant elastase inhibitors. Front Pharmacol 2020;11:688. DOI
PubMed PMC
48. Marinaccio L, Stefanucci A, Scioli G, et al. Peptide human neutrophil elastase inhibitors from natural sources: an overview. Int J Mol
Sci 2022;23:2924. DOI PubMed PMC
49. Wan H, Lee KS, Kim BY, et al. A spider-derived Kunitz-type serine protease inhibitor that acts as a plasmin inhibitor and an elastase
inhibitor. PLoS One 2013;8:e53343. DOI PubMed PMC
50. Luan N, Zhao Q, Duan Z, et al. Identification and characterization of ShSPI, a Kazal-type elastase inhibitor from the venom of
scolopendra hainanum. Toxins (Basel) 2019;11:708. DOI PubMed PMC
51. Al-Awadhi FH, Paul VJ, Luesch H. Structural diversity and anticancer activity of marine-derived elastase inhibitors: key features and
mechanisms mediating the antimetastatic effects in invasive breast cancer. Chembiochem 2018;19:815-25. DOI PubMed PMC
52. Luo D, Luesch H. Ahp-cyclodepsipeptide inhibitors of elastase: lyngbyastatin 7 stability, scalable synthesis, and focused library
analysis. ACS Med Chem Lett 2020;11:419-25. DOI PubMed PMC
53. Keller L, Canuto KM, Liu C, et al. Tutuilamides A-C: vinyl-chloride-containing cyclodepsipeptides from marine cyanobacteria with
potent elastase inhibitory properties. ACS Chem Biol 2020;15:751-7. DOI PubMed PMC
54. Crisford H, Sapey E, Stockley RA. Proteinase 3; a potential target in chronic obstructive pulmonary disease and other chronic
inflammatory diseases. Respir Res 2018;19:180. DOI PubMed PMC
55. Korkmaz B, Lesner A, Guarino C, et al. Inhibitors and antibody fragments as potential anti-inflammatory therapeutics targeting
neutrophil proteinase 3 in human disease. Pharmacol Rev 2016;68:603-30. DOI PubMed
56. Grzywa R, Lesner A, Korkmaz B, Sieńczyk M. Proteinase 3 phosphonic inhibitors. Biochimie 2019;166:142-9. DOI PubMed
57. Witko-Sarsat V, Thieblemont N. Granulomatosis with polyangiitis (Wegener granulomatosis): a proteinase-3 driven disease? Joint
Bone Spine 2018;85:185-9. DOI PubMed
58. Epinette C, Croix C, Jaquillard L, et al. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a
high affinity FRET substrate. Biochem Pharmacol 2012;83:788-96. DOI PubMed
59. Popow-Stellmaszyk J, Wysocka M, Lesner A, Korkmaz B, Rolka K. A new proteinase 3 substrate with improved selectivity over
human neutrophil elastase. Anal Biochem 2013;442:75-82. DOI PubMed
60. Guarino C, Legowska M, Epinette C, et al. New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking
neutrophil proteinase 3 in human diseases. J Biol Chem 2014;289:31777-91. DOI PubMed PMC
61. Guarino C, Gruba N, Grzywa R, et al. Exploiting the S4-S5 specificity of human neutrophil proteinase 3 to improve the potency of
peptidyl di(chlorophenyl)-phosphonate ester inhibitors: a kinetic and molecular modeling analysis. J Med Chem 2018;61:1858-70.
DOI PubMed